Rare
lephants
Screener
Toggle theme
Cresco Labs Inc.
CRLBF
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
Total Cash from Operations:
$78.9M
Line Item
Value
% of Total
Capital Expenditures
$39.4M
50.0%
Other Financing
$0
0.0%
Working Capital
$20.3M
25.7%
Other
$19.1M
24.3%
Net Cash Flow
$0
0.0%
Download CSV
